Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Rosner

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 27, 2001
A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapyP D Maguire, T V Samulski, L R Prosnitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863A P Venook, C Enders Klein, G Fleming, et al.
Radiation Research|February 1, 1997
Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressureJ S Hahn, R D Braun, M W Dewhirst, et al.
Blood Cancer Journal|September 10, 2013
Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapyL Qin, B D Smith, H-L Tsai, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 1999
The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapyL R Prosnitz, P Maguire, J M Anderson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 1996
Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomasD E Thrall, D M Prescott, T V Samulski, et al.
Pharmacological Reviews|June 1, 2004
PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5E G Schuetz, M V Relling, S Kishi, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 27, 2001
A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapyP D Maguire, T V Samulski, L R Prosnitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863A P Venook, C Enders Klein, G Fleming, et al.
Radiation Research|February 1, 1997
Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressureJ S Hahn, R D Braun, M W Dewhirst, et al.
Blood Cancer Journal|September 10, 2013
Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapyL Qin, B D Smith, H-L Tsai, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 1999
The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapyL R Prosnitz, P Maguire, J M Anderson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 1996
Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomasD E Thrall, D M Prescott, T V Samulski, et al.
Pharmacological Reviews|June 1, 2004
PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5E G Schuetz, M V Relling, S Kishi, et al.
Pageof 6